DACT3 and colorectal cancer: In a former study, DACT3 (a negative regulator of Wnt/β-catenin pathway) could inhibit Wnt/ß-catenin activity although the activating mark H3K4me3 remained at high levels near the DACT3 transcription start site in colorectal cancer cells [50].